Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: A meta-analysis Review uri icon

Overview

MeSH Major

  • Anticholesteremic Agents
  • Apolipoproteins B
  • Cardiovascular Diseases
  • Cholesterol
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypercholesterolemia

abstract

  • Among statin-treated patients, on-treatment levels of LDL-C, non-HDL-C, and apoB were each associated with risk of future major cardiovascular events, but the strength of this association was greater for non-HDL-C than for LDL-C and apoB.

publication date

  • March 21, 2012

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/jama.2012.366

PubMed ID

  • 22453571

Additional Document Info

start page

  • 1302

end page

  • 9

volume

  • 307

number

  • 12